Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VDMN-21 in Verruca Vulgaris
NCT05799157Phase 2Completed
- Sponsor
- Veradermics
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of candida antigen extract patch in verruca vulgaris, sponsored by Veradermics. Started Feb 2023; status: completed.
02
Drugs
candida antigen extract patch
03
Conditions
verruca vulgaris
Beyond the preview
Go deeper on NCT05799157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799157.